Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Tru2u vs Vea Health

Tru2u
Graded #244

Higher grade

vs+9.400000000000006
Vea Health
Graded #451

Lower grade

The verdict

Tru2u takes it — 64.4/100 to 55/100.

Tru2u grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tru2u is a US direct-to-consumer telehealth and wellness store offering provider-guided compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTru2u +11
56
45
Dose & formulationTru2u +32
83
51
Clinical oversightTru2u +2
68
66
Labs & monitoringVea Health +1
51
52
FulfillmentEven
68
68
Contract termsEven
55
55
Tru2u · left barVea Health · right bar

The numbers

MetricTru2uVea Health
WeighScore64.4/10055/100
GradeCC
Scorecard rank#244#451
Semaglutide$225/moNot disclosed
Tirzepatide$345/moNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Tru2u

Graded #244 · C

Strengths

  • Offers compounded semaglutide and tirzepatide plus a combined GLP Squared injection
  • Both injectable and oral GLP-1 tablet options available
  • Transparent upfront monthly pricing with free shipping

Where it loses points

  • No compounding pharmacy publicly named and no LegitScript seal shown
  • Tirzepatide at 345 dollars per month is higher than many compounded competitors
  • States served are not published; site states US-only availability
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard